154372-19-7

Upstream product

• 154459-79-7 1D-6-O-allyl-3-O-benzyl-1,2:4,5-di-O-cyclohexylidene-myo-inositol 
• 23393-20-6 1D-3-O-benzyl-1,2:4,5-di-O-cyclohexylidene-myo-inositol 
• 158110-45-3 (-)-3,4-di-O-benzyl-1,2:5,6-di-O-cyclohexylidene-myo-inositol 
• 152697-27-3 (-)-3,4-di-O-benzyl-1,2-O-cyclohexylidene-myo-inositol 
• 100-39-0 benzyl bromide 
• 6763-49-1 (+/-)-1,2:5,6-dicyclohexylidene-myo-inositol 
• 33021-17-9 (-)-2,3:4,5-di-O-cyclohexylidene-myo-inositol 
• 151426-85-6 (-)-6-O-allyl-3,4-di-O-benzyl-1,2-O-cyclohexylidene-myo-inositol 
• 154459-80-0 1D-6-O-allyl-3-O-benzyl-1,2-O-cyclohexylidene-myo-inositol 

Downstream Products

• 154372-20-0 1D-6-O-allyl-3,4,5-tri-O-benzyl-1-O-(4-methoxybenzoyl)-myo-inositol 
• 475650-88-5 (-)-2-O-hexadecanoyl-1-O-(p-methoxybenzyl)-3,4,5-tri-O-benzyl-myo-inositol 
• 475650-92-1 (-)-6-O-allyl-2-O-hexadecanoyl-1-O-(p-methoxybenzyl)-3,4,5-tri-O-benzyl-myo-inositol 
• 475650-99-8 6-O-[2-azido-3,6-di-O-benzyl-2-deoxy-4-O-(2-propenyl)-α-D-glucopyranosyl]-2-O-hexadecanoyl-1-O-(p-methoxybenzyl)-3,4,5-tri-O-benzyl-myo-inositol 
• 543698-59-5 6-O-(2-azido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranosyl)-2-O-hexadecanoyl-1-O-(p-methoxybenzyl)-3,4,5-tri-O-benzyl-myo-inositol 
• 154459-82-2 1-D-6-O-allyl-2,3,4,5-tetra-O-benzyl-1-O-(4-methoxybenzyl)-myo-inositol 
• 1041747-49-2 (3R,4R,5S,6R)-3-Azido-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[(1R,2S,3R,4R,5R,6R)-2,3,4,5-tetrakis-benzyloxy-6-(4-methoxy-benzyloxy)-cyclohexyloxy]-tetrahydro-pyran 
• 142436-07-5 2,3,4,5-O-Tetrabenzyl-D-myo-inositol 
• 133076-45-6 O-(2-azido-3,4,6-tri-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1->6)-2,3,4,5-tetra-O-benzyl-D-myo-inositol 
• 129261-63-8 (+)-1D-2,3,4,5-tetra-O-benzyl-1-O-(4-methoxybenzyl)-myo-inositol 
• 475651-00-4 6-O-[2-azido-3,6-di-O-benzyl-2-deoxy-4-O-(2-propenyl)-α-D-glucopyranosyl]-2-O-hexadecanoyl-3,4,5-tri-O-benzyl-myo-inositol 
• 154459-81-1 (-)-6-O-allyl-3,4,5-tri-O-benzyl-myo-inositol 

Relevant academic research and scientific papers

First total synthesis of a GPI-anchored peptide

A GPI-anchored dipeptide of sperm CD52 antigen was prepared through a convergent synthesis. First, the dipeptide with its C-terminus free and the GPI with its nonreducing end phosphoeth-anolamine bearing a free amino group were synthesized separately. Then, the two building blocks were coupled with use of EDC/HOBt as the condensation reagent. Finally, the GPI-anchored peptide was deprotected to give the target molecule 1.

Convergent synthesis of an inner core GPI of sperm CD52

An inner core of the GPI anchor of sperm CD52 antigens was synthesized by a highly convergent process using specially modified inositol, glucosamine and phospholipid as key building blocks. This paper also presents a new and efficient procedure to prepare

Parasite Glucoconjugates. Part 1. The Synthesis of Some Early and Related Intermediates in the Biosynthetic Pathway of Glycosyl-phosphatidylinositol Membrane Anchors

The enantio-pure 1D- and 1L-myo-inositol derivative 3D and 3L have been used to prepare sodium 1D-6-O-(2-amino-2-deoxy-α-D-glucopyranosyl)-myo-inositol sn-2,3-dipalmitoyloxypropyl phosphate 21 and a related 1,6-disubstituted 1L-myo-inositol 28, respective